These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 2863125)

  • 1. Pirbuterol. A preliminary review of its pharmacological properties and therapeutic efficacy in reversible bronchospastic disease.
    Richards DM; Brogden RN
    Drugs; 1985 Jul; 30(1):6-21. PubMed ID: 2863125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute bronchial and cardiovascular effects of oral pirbuterol and metaproterenol.
    Ence TJ; Tashkin DP; Ho D; Child JS
    Ann Allergy; 1979 Oct; 43(4):229-36. PubMed ID: 555600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of a hand-held, metered-dose aerosol delivery device to administer pirbuterol acetate to horses with 'heaves'.
    Derksen FJ; Olszewski M; Robinson NE; Berney C; Lloyd JW; Hakala J; Matson C; Ruth D
    Equine Vet J; 1996 Jul; 28(4):306-10. PubMed ID: 8818596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pirbuterol hydrochloride: evaluation of beta adrenergic agonist activity in reversible obstructive pulmonary disease and congestive heart failure.
    Weber RW; Nelson HS
    Pharmacotherapy; 1984; 4(1):1-10. PubMed ID: 6142449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of safety and efficacy of inhaled pirbuterol with metaproterenol.
    Tinkelman DG; Brandon ML; Grieco M; Hudson L; Rosenthal RR; Spector SL; Tashkin D; Votteri B
    Ann Allergy; 1990 Feb; 64(2 Pt 2):202-6. PubMed ID: 2405746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical efficacy of two beta 2-sympathicomimetics in different inhalers in children with asthma. Comparison of pirbuterol in a breath-actuated inhaler and salbutamol in a customary metered-dose inhaler.
    Völkl KP; Kroll VM; Wiesemann HG; Schneider B
    Arzneimittelforschung; 1991 May; 41(5):533-6. PubMed ID: 1680327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative investigations on pirbuterol, salbutamol and placebo aerosols in bronchial asthma.
    Beumer HM
    Int J Clin Pharmacol Biopharm; 1979 Jun; 17(6):237-9. PubMed ID: 381220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bitolterol. A preliminary review of its pharmacological properties and therapeutic efficacy in reversible obstructive airways disease.
    Friedel HA; Brogden RN
    Drugs; 1988 Jan; 35(1):22-41. PubMed ID: 3278878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Double-blind, clinical efficacy study comparing 400 micrograms of pirbuterol versus placebo delivered by a breath-actuated aerosol inhaler.
    Tinkelman DG; Vanden Burgt JA; Ekholm BP
    J Asthma; 1994; 31(3):187-92. PubMed ID: 7910819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of oral salbutamol and pirbuterol on FEV1, heart rate and blood pressure in asthmatics.
    Willey RF; Grant IW; Pocock SJ
    Br J Clin Pharmacol; 1976 Aug; 3(4):595-600. PubMed ID: 22216500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative effects of pirbuterol acetate, metaproterenol, and placebo aerosols on pulmonary function and incidence of cardiac ectopy.
    Chodosh S; Crooks LA; Tuck J
    J Asthma; 1989; 26(5):309-15. PubMed ID: 2484663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two oral beta-adrenergic stimulant drugs, pirbuterol and salbutamol, in reversible airway obstruction.
    Dyson AJ; Mackay AD
    Br J Dis Chest; 1980 Jan; 74(1):70-7. PubMed ID: 6101961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pirbuterol in the treatment of bronchial asthma.
    Beumer HM
    Int J Clin Pharmacol Biopharm; 1979 Jan; 17(1):18-25. PubMed ID: 367975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The effect of a single dose of formoterol using an aerosol inhaler in asthmatic children. A randomized, controlled, double-blind study].
    Lebecque P; Vliers S; De Saint-Moulin T; Godding V
    Rev Mal Respir; 1994; 11(1):47-50. PubMed ID: 7907426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pirbuterol versus orciprenaline aerosols in the treatment of bronchial asthma.
    Beumer HM
    Int J Clin Pharmacol Ther Toxicol; 1983 Mar; 21(3):147-66. PubMed ID: 6343262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparative studies on pirbuterol, salbutamol and a placebo administered as an aerosol in asthmatic patients].
    Verstraeten JM
    Rev Inst Hyg Mines (Hasselt); 1978; 33(4):200-3. PubMed ID: 552144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term treatment of bronchial asthma with pirbuterol aerosol.
    Beumer HM
    Int J Clin Pharmacol Ther Toxicol; 1983 Apr; 21(4):172-5. PubMed ID: 6862719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhaled formoterol during one year in asthma: a comparison with salbutamol.
    Arvidsson P; Larsson S; Löfdahl CG; Melander B; Svedmyr N; Wåhlander L
    Eur Respir J; 1991 Nov; 4(10):1168-73. PubMed ID: 1687129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Bronchial asthma treated with long-acting beta 2 agonist. Comparison between formoterol (12 mu/g) inhaled twice daily and salbutamol (200 mu/g) inhaled 4 times daily].
    Sprogøe-Jakobsen U; Viktrup L; Davidsen O; Viskum K
    Ugeskr Laeger; 1992 Nov; 154(47):3325-8. PubMed ID: 1361083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pirbuterol and salbutamol aerosol for exercise-induced bronchoconstriction].
    Aebischer JC; Benoit RC; Scherrer M
    Schweiz Med Wochenschr; 1984 Nov; 114(46):1660-4. PubMed ID: 6515368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.